Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (78)
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Faisal Ghiath — Director
Shares
122,174
Price
$0.41
Total Value
$50.01K
Shares Held After
125,574
% of Holdings
97.3%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$239.37
Total Value
$47.87K
Shares Held After
400
% of Holdings
50.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$236.24
Total Value
$47.25K
Shares Held After
200
% of Holdings
100.0%
Outlook Therapeutics, Inc. (OTLK)
Haddadin Yezan Munther — Director
Shares
34,000
Price
$0.44
Total Value
$14.96K
Shares Held After
37,167
% of Holdings
91.5%
Outlook Therapeutics, Inc. (OTLK)
THURMAN RANDY H — Director
Shares
5,000
Price
$0.43
Total Value
$2.15K
Shares Held After
5,593
% of Holdings
89.4%
Outlook Therapeutics, Inc. (OTLK)
HILZINGER KURT J — Director
Shares
400,000
Price
$0.44
Total Value
$176.52K
Shares Held After
423,655
% of Holdings
94.4%
Vaxart, Inc. (VXRT)
Watson W. Mark — Director
Shares
10,000
Price
$0.65
Total Value
$6.53K
Shares Held After
134,125
% of Holdings
7.5%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
10,000
Price
$1.93
Total Value
$19.30K
Shares Held After
20,000
% of Holdings
50.0%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$9.81
Total Value
$981.30K
Shares Held After
836,000
% of Holdings
12.0%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
10,000
Price
$1.77
Total Value
$17.70K
Shares Held After
10,000
% of Holdings
100.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Firestone Karen — Director
Shares
3,800
Price
$13.51
Total Value
$51.34K
Shares Held After
66,900
% of Holdings
5.7%
Kalaris Therapeutics, Inc. (KLRS)
AKKARAJU SRINIVAS — Director
Shares
244,300
Price
$4.83
Total Value
$1.18M
Shares Held After
2,224,147
% of Holdings
11.0%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,500
Price
$17.12
Total Value
$42.80K
Shares Held After
18,000
% of Holdings
13.9%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,563
Price
$64.43
Total Value
$100.71K
Shares Held After
490,000
% of Holdings
0.3%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
54,933
Price
$1.90
Total Value
$104.37K
Shares Held After
3,364,883
% of Holdings
1.6%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
18,849
Price
$1.80
Total Value
$33.93K
Shares Held After
3,309,950
% of Holdings
0.6%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
2,562
Price
$1.75
Total Value
$4.48K
Shares Held After
3,291,101
% of Holdings
0.1%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,500
Price
$0.92
Total Value
$1.38K
Shares Held After
293,266
% of Holdings
0.5%
Entrada Therapeutics, Inc. (TRDA)
Zeiher Bernhardt G — Director
Shares
5,000
Price
$5.86
Total Value
$29.32K
Shares Held After
5,000
% of Holdings
100.0%
Serina Therapeutics, Inc. (SER)
Marshall Richard Peter — Director
Shares
12,183
Price
$1.65
Total Value
$20.10K
Shares Held After
12,183
% of Holdings
100.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
200
Price
$0.95
Total Value
$190.00
Shares Held After
291,766
% of Holdings
0.1%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200,000
Price
$1.50
Total Value
$299.80K
Shares Held After
800,000
% of Holdings
25.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200,000
Price
$1.56
Total Value
$312.08K
Shares Held After
600,000
% of Holdings
33.3%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
68,551
Price
$1.60
Total Value
$109.67K
Shares Held After
400,000
% of Holdings
17.1%
RenovoRx, Inc. (RNXT)
VOLL MARK — Chief Financial Officer
Shares
25,000
Price
$0.79
Total Value
$19.69K
Shares Held After
142,380
% of Holdings
17.6%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200
Price
$13.80
Total Value
$2.76K
Shares Held After
926,352
% of Holdings
0.0%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
10,000
Price
$13.98
Total Value
$139.82K
Shares Held After
926,152
% of Holdings
1.1%
Liquidia Corp (LQDA)
Caligan Partners LP — Director
Shares
5,300
Price
$59.98
Total Value
$317.89K
Shares Held After
8,138,951
% of Holdings
0.1%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
2,200
Price
$1.68
Total Value
$3.70K
Shares Held After
3,529
% of Holdings
62.3%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
6,009
Price
$13.98
Total Value
$83.98K
Shares Held After
916,152
% of Holdings
0.7%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
500
Price
$1.65
Total Value
$825.00
Shares Held After
1,329
% of Holdings
37.6%
Corvus Pharmaceuticals, Inc. (CRVS)
MILLER RICHARD A MD — Director
Shares
1,932
Price
$12.01
Total Value
$23.20K
Shares Held After
1,195,035
% of Holdings
0.2%
Corvus Pharmaceuticals, Inc. (CRVS)
MILLER RICHARD A MD — Director
Shares
5,000
Price
$12.05
Total Value
$60.25K
Shares Held After
1,193,103
% of Holdings
0.4%
CNS Pharmaceuticals, Inc. (CNSP)
Charles Faith L. — Director
Shares
7,100
Price
$4.79
Total Value
$34.00K
Shares Held After
7,100
% of Holdings
100.0%
Orchestra BioMed Holdings, Inc. (OBIO)
Aryeh Jason — Director
Shares
665
Price
$3.75
Total Value
$2.49K
Shares Held After
118,118
% of Holdings
0.6%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
60,000
Price
$16.88
Total Value
$1.01M
Shares Held After
96,928
% of Holdings
61.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,700
Price
$0.92
Total Value
$5.24K
Shares Held After
291,566
% of Holdings
2.0%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.58
Total Value
$10.58K
Shares Held After
9,450
% of Holdings
10.6%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
1,843
Price
$2.97
Total Value
$5.47K
Shares Held After
7,841
% of Holdings
23.5%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,545
Price
$2.97
Total Value
$4.59K
Shares Held After
15,345
% of Holdings
10.1%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,369
Price
$2.97
Total Value
$4.07K
Shares Held After
7,594
% of Holdings
18.0%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
1,984
Price
$2.97
Total Value
$5.89K
Shares Held After
8,466
% of Holdings
23.4%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,583
Price
$2.97
Total Value
$4.70K
Shares Held After
8,011
% of Holdings
19.8%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
5,000
Price
$3.77
Total Value
$18.85K
Shares Held After
1,059,029
% of Holdings
0.5%
Orchestra BioMed Holdings, Inc. (OBIO)
Aryeh Jason — Director
Shares
8,971
Price
$3.90
Total Value
$34.99K
Shares Held After
117,453
% of Holdings
7.6%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
5,000
Price
$20.70
Total Value
$103.50K
Shares Held After
43,415
% of Holdings
11.5%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200
Price
$13.95
Total Value
$2.79K
Shares Held After
910,143
% of Holdings
0.0%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
100
Price
$13.80
Total Value
$1.38K
Shares Held After
909,943
% of Holdings
0.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,100
Price
$1.02
Total Value
$5.20K
Shares Held After
285,866
% of Holdings
1.8%
AbCellera Biologics Inc. (ABCL)
Montalbano John S. — Director
Shares
20,000
Price
$4.77
Total Value
$95.40K
Shares Held After
241,000
% of Holdings
8.3%
Showing 1–50 of 78 transactions (page 1 of 2)